Linked Life Data

16622691

Source:http://linkedlifedata.com/resource/pubmed/id/16622691

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-11-22
pubmed:abstractText
Treatment options in patients with recurrent non-small cell lung cancer (NSCLC) remain limited as a result of poor activity of most agents after failure of platinum-based therapy. In the present phase I-II study, we evaluated the feasibility and efficacy of bi-weekly gemcitabine (GEM) + irinotecan (CPT-11) in patients with relapsed NSCLC.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0344-5704
pubmed:author
pubmed:issnType
Print
pubmed:volume
59
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
51-9
pubmed:meshHeading
pubmed-meshheading:16622691-Adult, pubmed-meshheading:16622691-Aged, pubmed-meshheading:16622691-Antibiotics, Antineoplastic, pubmed-meshheading:16622691-Antineoplastic Agents, pubmed-meshheading:16622691-Antineoplastic Agents, Phytogenic, pubmed-meshheading:16622691-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16622691-Blood Cell Count, pubmed-meshheading:16622691-Bridged Compounds, pubmed-meshheading:16622691-Camptothecin, pubmed-meshheading:16622691-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:16622691-Deoxycytidine, pubmed-meshheading:16622691-Diarrhea, pubmed-meshheading:16622691-Dose-Response Relationship, Drug, pubmed-meshheading:16622691-Female, pubmed-meshheading:16622691-Humans, pubmed-meshheading:16622691-Lung Neoplasms, pubmed-meshheading:16622691-Male, pubmed-meshheading:16622691-Middle Aged, pubmed-meshheading:16622691-Neutropenia, pubmed-meshheading:16622691-Organoplatinum Compounds, pubmed-meshheading:16622691-Patient Compliance, pubmed-meshheading:16622691-Quality of Life, pubmed-meshheading:16622691-Survival Analysis, pubmed-meshheading:16622691-Taxoids
pubmed:year
2007
pubmed:articleTitle
A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.
pubmed:affiliation
Second Division of Medical Oncology, Department of Medicine, "Metaxa" Cancer Hospital, Piraues, 21 Apolloniou Street, 16341, Athens, Greece. ckosm@ath.forthnet.gr
pubmed:publicationType
Journal Article, Clinical Trial, Phase II, Clinical Trial, Phase I